Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.4%

1 terminated/withdrawn out of 272 trials

Success Rate

98.2%

+11.7% vs industry average

Late-Stage Pipeline

15%

41 trials in Phase 3/4

Results Transparency

0%

0 of 56 completed trials have results

Key Signals

69 recruiting

Enrollment Performance

Analytics

N/A
98(51.6%)
Phase 2
46(24.2%)
Phase 3
29(15.3%)
Phase 4
12(6.3%)
Phase 1
4(2.1%)
Early Phase 1
1(0.5%)
190Total
N/A(98)
Phase 2(46)
Phase 3(29)
Phase 4(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (272)

Showing 20 of 272 trials
NCT07644390Completed

Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort Study

Role: lead

NCT07328958Not ApplicableRecruiting

Effect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial

Role: lead

NCT06510010Phase 2Recruiting

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Role: lead

NCT03748485Not ApplicableRecruiting

Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis

Role: lead

NCT07510191Phase 4Recruiting

TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

Role: lead

NCT07176182Phase 2Recruiting

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

Role: lead

NCT07601256Not ApplicableNot Yet Recruiting

Inhalational Versus Intravenous Anesthesia on Postoperative Lung Injury in Septic Patients Undergoing Surgery

Role: lead

NCT04053205Phase 1Completed

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Role: collaborator

NCT07504510Recruiting

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

Role: lead

NCT07597577Completed

Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's Disease

Role: lead

NCT07239557Not ApplicableEnrolling By Invitation

Optimal Interval for Periodic Alveolar Recruitment Maneuvers Achieving 90% Lung Re-expansion During Intraoperative Ventilation

Role: lead

NCT07579780Not ApplicableRecruiting

Superior HypogastrIc plExus bLock During Laparoscopic Colorectal Cancer Surgery

Role: lead

NCT07566819Not ApplicableNot Yet Recruiting

Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Laparoscopic Cholecystectomy

Role: lead

NCT07571902Not ApplicableNot Yet Recruiting

Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Stoma Closure

Role: lead

NCT07567950Not ApplicableNot Yet Recruiting

Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Video-assisted Thoracoscopic Pneumonectomy

Role: lead

NCT05174208Completed

Study of Imaginomics Predicting Early Surgical Rates in Crohn's Disease

Role: lead

NCT05642247Completed

Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science

Role: lead

NCT07555808Completed

MRI-Based Screening in a Retrospective Cohort Reveals Adverse Prognosis of Asymptomatic Perianal Fistulas in Crohn's Disease: A Long-term Follow-Up Study

Role: lead

NCT05205603Phase 4Completed

Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis

Role: lead

NCT06095596Not ApplicableRecruiting

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

Role: lead